The most common dermatology diagnoses in the emergency department - 14/11/16
Funding sources: None. |
|
The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. Dr Feldman is a speaker for Janssen and Novartis and has received grants from Galderma Laboratories, L.P., Janssen, Abbvie, Amgen, Stiefel/GlaxoSmithKline, Celgene, and Anacor. He is a consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, Hanall Pharmaceutical Co Ltd, Lilly, Merck, Mylan, Novartis, Pfizer, Qurient, Suncare Research, and Xenoport. Dr Feldman is the founder of and holds stock in Causa Research and holds stock and is majority owner in Medical Quality Enhancement Corporation and the www.DrScore.com doctor rating/patient satisfaction website. He receives royalties from UpToDate and Xlibris. Dr Hill's translational research is funded by Janssen Scientific Affairs, LLC. Mr. Nadkarni and Mrs. Domeisen have no conflicts of interest to disclose. |
Vol 75 - N° 6
P. 1261-1262 - décembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?